These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7507098)

  • 1. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells.
    Eisenhut T; Sinha B; Gröttrup-Wolfers E; Semmler J; Siess W; Endres S
    Immunopharmacology; 1993; 26(3):259-64. PubMed ID: 7507098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.
    Crutchley DJ; Conanan LB; Que BG
    J Pharmacol Exp Ther; 1994 Oct; 271(1):446-51. PubMed ID: 7525928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin I2 analogs suppress tumor necrosis factor α production and the maturation of human monocyte-derived dendritic cells.
    Yeh CH; Kuo CH; Yang SN; Huang MY; Wu HC; Wang HP; Kuo TH; Hung CH
    J Investig Med; 2011 Oct; 59(7):1109-15. PubMed ID: 21716128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of intracellular tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 production in human monocytes by iloprost.
    Czeslick EG; Simm A; Grond S; Silber RE; Sablotzki A
    Eur J Clin Invest; 2003 Nov; 33(11):1013-7. PubMed ID: 14636306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins.
    Schwaner I; Seifert R; Schultz G
    Eicosanoids; 1992; 5 Suppl():S10-2. PubMed ID: 1280455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.
    Crutchley DJ; Solomon DE; Conanan LB
    Arterioscler Thromb; 1992 Jun; 12(6):664-70. PubMed ID: 1375507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production.
    Eigler A; Siegmund B; Emmerich U; Baumann KH; Hartmann G; Endres S
    J Leukoc Biol; 1998 Jan; 63(1):101-7. PubMed ID: 9469479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.
    Hart PH; Whitty GA; Piccoli DS; Hamilton JA
    Immunology; 1989 Mar; 66(3):376-83. PubMed ID: 2495247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesis.
    Greten TF; Sinha B; Haslberger C; Eigler A; Endres S
    Eur J Pharmacol; 1996 Mar; 299(1-3):229-33. PubMed ID: 8901027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents.
    Siegmund B; Eigler A; Moeller J; Greten TF; Hartmann G; Endres S
    Eur J Pharmacol; 1997 Feb; 321(2):231-9. PubMed ID: 9063693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells.
    Endres S; Fülle HJ; Sinha B; Stoll D; Dinarello CA; Gerzer R; Weber PC
    Immunology; 1991 Jan; 72(1):56-60. PubMed ID: 1847694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of Gi and Gs proteins by E- and I-type prostaglandins in membranes from the human erythroleukaemia cell line, HEL.
    Schwaner I; Offermanns S; Spicher K; Seifert R; Schultz G
    Biochim Biophys Acta; 1995 Feb; 1265(1):8-14. PubMed ID: 7532011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prostacyclin analogues on human endothelial cell tissue factor expression.
    Crutchley DJ; Conanan LB; Toledo AW; Solomon DE; Que BG
    Arterioscler Thromb; 1993 Jul; 13(7):1082-9. PubMed ID: 7686394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cytokine release from mononuclear cells by prostacyclin, IL-4 and IL-13.
    Luttmann W; Herzog V; Matthys H; Thierauch KH; Virchow JC; Kroegel C
    Cytokine; 1999 Feb; 11(2):127-33. PubMed ID: 10089133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation.
    Friedlander MA; Hilbert CM; Wu YC; Rich EA
    Am J Kidney Dis; 1993 Jul; 22(1):11-23. PubMed ID: 8322772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of TPA on PGE2 and cicaprost-induced cAMP synthesis in UMR-106 cells.
    Khanin M; Liel Y; Rimon G
    Cell Signal; 1999 Mar; 11(3):165-9. PubMed ID: 10353690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: cellular mechanisms.
    Jörres A; Dinter H; Topley N; Gahl GM; Frei U; Scholz P
    Cytokine; 1997 Feb; 9(2):119-25. PubMed ID: 9071563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the prostaglandin E2-ethanolamide suppression of tumour necrosis factor-α production in human monocytic cells.
    Brown KL; Davidson J; Rotondo D
    Biochim Biophys Acta; 2013 Jun; 1831(6):1098-107. PubMed ID: 23542062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.